Replies to post #181207 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Yes, but, in looking at this statement from the post I responded to I take it to be another trial might be something you desire to see.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=131165476

If B-UP is found to be successful, another potential avenue of exploration can be its use for GI ulcers in the upper GI tract based on its anti-inflammatory and biofilm properties.

The great thing is Brilacidin is proving out to have great potential value.
I'm especially happy to see the interim results shown in Oral Mucositis thus far.




In Reply to 'mdphd2008'
This would be an extension to the Brilacidin GI platform. Ulcerative colitis and proctitis are inflammatory conditions of the lower GI tract.